Search by Drug Name or NDC
NDC 51862-0376-60 SORILUX 50 ug/g Details
SORILUX 50 ug/g
SORILUX is a TOPICAL AEROSOL, FOAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mayne Pharma. The primary component is CALCIPOTRIENE.
MedlinePlus Drug Summary
Calcipotriene is used to treat psoriasis (a skin disease in which red, scaly patches form due to increased production of skin cells on some areas of the body). Calcipotriene is in a class of medications called synthetic vitamin D3 derivatives. It works by slowing the excessive production of skin cells.
Related Packages: 51862-0376-60Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Calcipotriene Topical
Product Information
| NDC | 51862-0376 |
|---|---|
| Product ID | 51862-376_0ab6061c-756f-48e6-ac67-cc6c15a5a752 |
| Associated GPIs | 90250025003920 |
| GCN Sequence Number | 069246 |
| GCN Sequence Number Description | calcipotriene FOAM 0.005 % TOPICAL |
| HIC3 | L5F |
| HIC3 Description | ANTIPSORIATICS AGENTS |
| GCN | 32228 |
| HICL Sequence Number | 013331 |
| HICL Sequence Number Description | CALCIPOTRIENE |
| Brand/Generic | Brand |
| Proprietary Name | SORILUX |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | calcipotriene |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | AEROSOL, FOAM |
| Route | TOPICAL |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | ug/g |
| Substance Name | CALCIPOTRIENE |
| Labeler Name | Mayne Pharma |
| Pharmaceutical Class | Vitamin D Analog [EPC], Vitamin D [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022563 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51862-0376-60 (51862037660)
| NDC Package Code | 51862-376-60 |
|---|---|
| Billing NDC | 51862037660 |
| Package | 1 CAN in 1 CARTON (51862-376-60) / 60 g in 1 CAN |
| Marketing Start Date | 2017-04-11 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |